These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7772081)

  • 61. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia.
    Simons LA
    Am J Cardiol; 2002 Oct; 90(7):737-40. PubMed ID: 12356387
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
    Stein EA; Davidson MH; Dobs AS; Schrott H; Dujovne CA; Bays H; Weiss SR; Melino MR; Stepanavage ME; Mitchel YB
    Am J Cardiol; 1998 Aug; 82(3):311-6. PubMed ID: 9708659
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of niacin, statins, and resins in patients with combined hyperlipidemia.
    Brown BG; Zambon A; Poulin D; Rocha A; Maher VM; Davis JW; Albers JJ; Brunzell JD
    Am J Cardiol; 1998 Feb; 81(4A):52B-59B. PubMed ID: 9526815
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High-performance capillary electrophoresis-pure creatine monohydrate reduces blood lipids in men and women.
    Earnest CP; Almada AL; Mitchell TL
    Clin Sci (Lond); 1996 Jul; 91(1):113-8. PubMed ID: 8774269
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Short-term effects of substituting protein for carbohydrate in the diets of moderately hypercholesterolemic human subjects.
    Wolfe BM; Giovannetti PM
    Metabolism; 1991 Apr; 40(4):338-43. PubMed ID: 2011075
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia.
    Tonstad S; Ose L; Gørbitz C; Harrison EM; de Koning Gans HJ
    Scand J Clin Lab Invest; 1993 Aug; 53(5):457-63. PubMed ID: 8210967
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia.
    Maki KC; Lawless AL; Reeves MS; Kelley KM; Dicklin MR; Jenks BH; Shneyvas E; Brooks JR
    Nutrition; 2013 Jan; 29(1):96-100. PubMed ID: 22796122
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
    Malloy MJ; Kane JP; Kunitake ST; Tun P
    Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men.
    Teixeira SR; Potter SM; Weigel R; Hannum S; Erdman JW; Hasler CM
    Am J Clin Nutr; 2000 May; 71(5):1077-84. PubMed ID: 10799368
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ameliorating Effects of Four-Week Fiber-Multivitamin Combination Treatment on Low-Density Lipoprotein Cholesterol, Total Cholesterol, and Apolipoprotein B Profiles in Hypercholesterolemic Participants.
    Anggadiredja K; Ufamy N; Amalia L; Fisheri Kurniati N; Bahana Maulida Reyaan I
    J Diet Suppl; 2020; 17(2):173-183. PubMed ID: 30380357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    Ballantyne CM; Davidson MH; Macdougall DE; Bays HE; Dicarlo LA; Rosenberg NL; Margulies J; Newton RS
    J Am Coll Cardiol; 2013 Sep; 62(13):1154-62. PubMed ID: 23770179
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.
    Rosenson RS; Jacobson TA; Preiss D; Djedjos CS; Dent R; Bridges I; Miller M
    Cardiovasc Drugs Ther; 2016 Jun; 30(3):305-13. PubMed ID: 27240673
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized dose-response study of rosuvastatin in Japanese patients with hypercholesterolemia.
    Saito Y; Goto Y; Dane A; Strutt K; Raza A
    J Atheroscler Thromb; 2003; 10(6):329-36. PubMed ID: 15037821
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study.
    Wilt TJ; Lofgren RP; Nichol KL; Schorer AE; Crespin L; Downes D; Eckfeldt J
    Ann Intern Med; 1989 Dec; 111(11):900-5. PubMed ID: 2683921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.